Profile data is unavailable for this security.
About the company
Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).
- Revenue in SEK (TTM)15.25bn
- Net income in SEK826.00m
- Incorporated1972
- Employees4.66k
- LocationElekta AB (publ)Kungstensgatan 18STOCKHOLM 11357SwedenSWE
- Phone+46 85 872544646
- Fax+46 858725500
- Websitehttps://www.elekta.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CellaVision AB | 651.19m | 125.79m | 6.01bn | 234.00 | 47.78 | 9.92 | 36.37 | 9.23 | 5.27 | 5.27 | 27.30 | 25.40 | 0.8102 | 1.72 | 7.64 | 3,255,925.00 | 15.65 | 18.72 | 18.52 | 22.72 | 69.28 | 70.70 | 19.32 | 21.74 | 1.85 | 14.75 | 0.1552 | 29.04 | 19.96 | 16.37 | 40.07 | 15.95 | 29.89 | 5.92 |
| Xvivo Perfusion AB | 369.64m | 29.88m | 6.19bn | 118.00 | 207.49 | 4.48 | 83.90 | 16.75 | 1.01 | 1.01 | 12.48 | 46.74 | 0.2654 | 1.24 | 4.90 | 4,017,837.00 | 2.15 | -0.3034 | 2.27 | -0.3258 | 71.75 | 73.36 | 8.08 | -1.18 | 4.82 | -- | 0.004 | -- | 43.66 | 13.34 | 118.64 | 40.27 | 35.61 | -- |
| Synsam AB (publ) | 5.15bn | 324.00m | 6.46bn | 3.25k | 19.94 | 2.53 | 6.80 | 1.25 | 2.16 | 2.16 | 34.33 | 17.02 | 0.6659 | 2.34 | 14.05 | -- | 4.20 | -- | 5.75 | -- | 76.35 | -- | 6.31 | -- | 0.5971 | 2.16 | 0.621 | -- | 22.67 | -- | 126.15 | -- | -- | -- |
| BICO Group AB | 2.08bn | 40.80m | 7.30bn | 1.27k | 178.39 | 0.9234 | 22.83 | 3.50 | 0.5923 | 0.5923 | 32.54 | 114.41 | 0.2372 | 0.9126 | 3.76 | 2,342,135.00 | 0.4586 | -- | 0.5044 | -- | 81.72 | -- | 1.93 | -- | 1.55 | -- | 0.2002 | -- | -- | -- | -- | -- | -- | -- |
| Arjo AB (publ) | 9.98bn | 447.00m | 10.31bn | 6.69k | 24.71 | 1.45 | 6.76 | 1.03 | 1.64 | 1.64 | 36.64 | 27.99 | 0.6484 | 3.79 | 6.14 | -- | 2.90 | 3.44 | 4.52 | 5.33 | 42.20 | 44.39 | 4.47 | 5.34 | 0.7369 | 7.51 | 0.453 | 42.64 | 10.02 | 5.35 | -39.76 | 30.52 | -- | 11.20 |
| Biotage AB | 1.52bn | 239.00m | 10.68bn | 510.00 | 44.81 | 6.68 | 32.08 | 7.01 | 3.61 | 3.61 | 23.04 | 24.23 | 0.8002 | 2.30 | 7.02 | 3,066,399.00 | 12.55 | 14.87 | 15.33 | 17.80 | 61.29 | 61.37 | 15.68 | 17.18 | 1.75 | 11.60 | 0.1097 | 44.47 | 12.79 | 13.03 | 16.92 | 17.18 | 3.33 | 4.40 |
| Revenio Group Oyj | 1.03bn | 241.77m | 11.22bn | 191.00 | 46.41 | 11.63 | 39.30 | 10.85 | 0.8106 | 0.8106 | 3.47 | 3.23 | 0.7678 | 7.20 | 8.33 | 502,597.80 | 17.87 | 16.31 | 21.17 | 19.98 | 50.96 | 51.88 | 23.27 | 22.28 | 1.78 | -- | 0.2054 | 69.84 | 29.00 | 27.44 | 29.63 | 24.25 | 9.80 | -14.40 |
| Ossur hf | 7.34bn | 484.30m | 21.99bn | 3.67k | 46.27 | 3.53 | 21.49 | 2.99 | 0.7471 | 0.7471 | 11.46 | 9.78 | 0.5657 | 2.41 | 6.73 | 1,331,360.00 | 3.80 | 5.59 | 4.86 | 6.50 | 62.13 | 63.03 | 6.71 | 8.70 | 0.5755 | 11.48 | 0.4249 | 10.07 | 14.16 | 6.65 | 929.84 | 4.63 | 1.66 | -- |
| Elekta AB (publ) | 15.25bn | 826.00m | 28.01bn | 4.66k | 35.16 | 3.18 | 14.94 | 1.84 | 2.16 | 2.16 | 39.91 | 23.89 | 0.5972 | 3.40 | 2.84 | 3,209,640.00 | 3.25 | 4.84 | 5.99 | 8.86 | 37.12 | 41.03 | 5.44 | 8.88 | 0.7558 | 4.65 | 0.3847 | 55.05 | 5.70 | 6.33 | -7.97 | 55.98 | 12.71 | 19.14 |
| Ambu A/S | 6.68bn | 139.84m | 32.92bn | 4.41k | 263.71 | 5.84 | 57.01 | 4.93 | 0.3716 | 0.3716 | 17.53 | 16.77 | 0.6861 | 1.92 | 6.15 | 1,007,938.00 | 1.44 | 5.08 | 1.72 | 6.27 | 57.47 | 59.90 | 2.09 | 7.08 | 0.932 | -- | 0.3022 | 34.01 | 10.74 | 13.54 | -62.35 | -20.94 | 28.54 | -- |
| GN Store Nord A/S | 26.34bn | 1.01bn | 37.87bn | 8.17k | 35.16 | 3.26 | 11.42 | 1.44 | 5.22 | 5.22 | 136.80 | 56.29 | 0.7187 | 3.06 | 4.89 | 2,423,492.00 | 2.95 | 9.04 | 4.38 | 12.20 | 51.42 | 58.31 | 4.11 | 11.12 | 0.5192 | 5.59 | 0.6911 | 33.63 | 17.29 | 12.77 | 40.26 | 10.09 | 14.20 | 6.15 |
| Getinge AB | 27.78bn | 2.71bn | 59.73bn | 11.11k | 23.64 | 2.10 | 13.19 | 2.15 | 9.94 | 9.94 | 102.00 | 111.80 | 0.5829 | 2.48 | 6.71 | 2,589,337.00 | 5.73 | 3.34 | 6.90 | 4.45 | 48.67 | 48.06 | 9.83 | 5.78 | 1.43 | 30.71 | 0.151 | 40.67 | -9.29 | 4.06 | -8.31 | 33.59 | -10.36 | 15.20 |
| Demant A/S | 28.05bn | 3.98bn | 68.45bn | 18.13k | 17.20 | 5.80 | -- | 2.44 | 11.49 | 10.37 | 81.12 | 34.06 | 0.7328 | 2.05 | 5.31 | 1,106,131.00 | 10.42 | 9.07 | 18.49 | 14.78 | 75.16 | 75.23 | 14.22 | 11.96 | 0.5879 | 45.49 | 0.6212 | 0.00 | 23.75 | 8.33 | 140.50 | 13.07 | 11.99 | -- |
Data as of Jan 27 2023. Currency figures normalised to Elekta AB (publ)'s reporting currency: Swedish Krona SEK
40.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fj�rde AP-fondenas of 31 Jan 2022 | 33.68m | 9.14% |
| Nordea Investment Management ABas of 30 Nov 2022 | 19.08m | 5.18% |
| SEB Investment Management ABas of 31 Jan 2022 | 15.52m | 4.21% |
| Schroder Investment Management Ltd.as of 31 Jan 2022 | 13.67m | 3.71% |
| AMF Fonder ABas of 31 Oct 2021 | 12.83m | 3.48% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 2022 | 12.29m | 3.33% |
| Lannebo Fonder ABas of 31 Jan 2022 | 10.74m | 2.92% |
| Swedbank Robur Fonder ABas of 31 Jan 2022 | 10.45m | 2.84% |
| The Vanguard Group, Inc.as of 05 Jan 2023 | 10.05m | 2.73% |
| Didner & Gerge Fonder ABas of 31 Dec 2021 | 9.15m | 2.48% |
More ▼
Data from 31 Dec 2021 - 30 Dec 2022Source: FactSet Research Systems Inc.
